XDXuehui Duan

Xuehui Duan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuehui Duan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Hanxiao Liu

    School of Pharmacy, Weifang Medical University, Weifang, Shandong, 261053, People’s Republic of China

    1 shared publication
  • Hui Lv

    Department of Pharmacy, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, 250014, People’s Republic of China

    1 shared publication
  • Wei Xu

    School of Pharmacy, Weifang Medical University, Weifang, Shandong, 261053, People’s Republic of China

    1 shared publication
  • Yan Du

    School of Pharmaceutical Sciences & Institute of Materia Medica, National Key Laboratory of Advanced Drug Delivery System, Medical Science and Technology Innovation Center, Key Laboratory for Biotechnology Drugs of National Health Commission, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, People’s Republic of China

    1 shared publication
  • Yixuan Tang

    School of Pharmaceutical Sciences & Institute of Materia Medica, Medical Science and Technology Innovation Center, Key Laboratory for Biotechnology Drugs of National Health Commission, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China

    1 shared publication

Latest Publications

  • Open Access

    Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management

    by Hanxiao Liu, Hui Lv, Xuehui Duan, Yan Du, Yixuan Tang, Wei Xu

    Macrophages play a crucial role in tissue homeostasis and the innate immune system. They perform essential functions such as presenting antigens, regulating cytokines, and responding to inflammation. However, in diseases like cancer, cardiovascular disorders, and autoimmune conditions, macrophages undergo aberrant polarization, which disrupts tissue regulation and impairs their normal behavior. To address these challenges, there has been growing interest in developing customized targeted drug delivery systems specifically designed for macrophage-related functions in different anatomical locations. Nanomedicine, utilizing nanoscale drug systems, offers numerous advantages including improved stability, enhanced pharmacokinetics, controlled release kinetics, and precise temporal drug delivery. These advantages hold significant promise in achieving heightened therapeutic efficacy, specificity, and reduced side effects in drug delivery and treatment approaches. This review aims to explore the roles of macrophages in major diseases and present an overview of current strategies employed in targeted drug delivery to macrophages. Additionally, this article critically evaluates the design of macrophage-targeted delivery systems, highlighting limitations and discussing prospects in this rapidly evolving field. By assessing the strengths and weaknesses of existing approaches, we can identify areas for improvement and refinement in macrophage-targeted drug delivery.